Chairman intends to retire from Almirall in May

Jorge Gallardo Ballart wants to retire from his positions as chair and member of Almirall’s board, effective from the end of the company’s general shareholders meeting in May. Current board vice-president, Carlos Gallardo Piqué, will replace Ballart.

Photo: Almirall / PR

Spanish dermatology group Almirall, which is behind the recent launch of Danish firm MC2 Therapeutics’s psoriasis cream Wynzora in Europe, will soon make a change to the company’s board of direction, as announced in a press release.

Almirall’s current chair, Jorge Gallardo Ballart, wants to step down from both of his board positions as chairman and member on May 6, when the company’s general shareholder meeting ends.

Already a subscriber? Log in.

Read the whole article

Get access for 14 days for free.
No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.

  • Access all locked articles
  • Receive our daily newsletters
  • Access our app
An error has occured. Please try again later.

Get full access for you and your coworkers.

Start a free company trial today

More from MedWatch

Further reading

Related articles

Latest news

See all jobs